Investigational Drug Services, University of Pennsylvania — Philadelphia, Pennsylvania

Investigational Drug Services, University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Services, University of Pennsylvania has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Services, University of Pennsylvania?

Investigational Drug Services, University of Pennsylvania has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Services, University of Pennsylvania conducted?

Investigational Drug Services, University of Pennsylvania has 1 clinical trials on record. Their work covers Ovarian Cancer.

Is Investigational Drug Services, University of Pennsylvania accredited by Crixeo Health?

Investigational Drug Services, University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Services, University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.